Aktienanalyse zu Varex Imaging Corp (VREX)VREXVarex Imaging Corp

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals. It operates in the Healthcare sector (ELECTRONIC COMPONENTS, NEC industry).

Varex Imaging Corp (VREX) is currently trading at $18.41, which is below the acquisition price of $18.90 per share offered by Teledyne Technologies. The stock has shown a significant year-to-date increase of 58.03%, but the RSI is at 41.048, indicating it is nearing oversold territory. The main risk is the recent downgrade by Sidoti, which could signal potential volatility as the acquisition progresses.

3 analysts cover VREX: 2 rate it Buy, 0 Hold and 1 Sell. The average price target is 17.00.